Home » Newsletters » BioWorld

BioWorld

Nov. 30, 2009

View Archived Issues

Strong at the Broken Places: Models for Industry's Future

There's a lot of talk these days about how the biotech industry's business models are broken. Read More

Money Raised Year to Date

Tetchy HCV Sector Sleepy Over InterMune; Revival Due in 2010?

Money Raised By Biotech in 2009

Week in Review

Word on the Street

Week in Washington

Collaborations Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009

Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Oct. 1 - Nov. 24, 2009

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...